Genomic Health today announced the presentation of new data with the Oncotype DX® test at the 11th European Breast Cancer Conference (EBCC-11) in Barcelona, Spain

The presentations underline the substantial real-world evidence available for Oncotype DX and reflect the growing adoption of the test across Europe to personalize and improve the quality of clinical decisions, leading to better patient outcomes and more cost-effective treatment.

Access to the full press release

Find an actor

MedTech Investing Europe 2018 (MTi)24.04.2018

The 26th MedTech Investing Europe Conference will be held on 24 and 25 April 2018 at the Royal Savoy Hotel in...

Anergis and Mymetics Start Research Collaboration Project

Mymetics Corporation (OTCQB:MYMX), a pioneer and leader in the research and development of virosome-based vaccines,...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn